-
1
-
-
0012510759
-
Amyloid plaque core protein in Alzheimer disease and down syndrome
-
1. Masters, C.L. et al. 1985. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82: 4245-4249.
-
(1985)
Proc. Natl. Acad. Sci. USA
, vol.82
, pp. 4245-4249
-
-
Masters, C.L.1
-
2
-
-
0025879957
-
An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance P
-
2. Kowall, N.W. et al. 1991. An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA 88: 7247-7251.
-
(1991)
Proc. Natl. Acad. Sci. USA
, vol.88
, pp. 7247-7251
-
-
Kowall, N.W.1
-
3
-
-
0028177692
-
β-amyloid protein-induced Alzheimer's disease animal model
-
3. Nitta, A. et al. 1994. β-amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 170: 63-66.
-
(1994)
Neurosci. Lett.
, vol.170
, pp. 63-66
-
-
Nitta, A.1
-
4
-
-
0024990330
-
Neurotrophic and neurotoxic effects of amyloid β-protein: Reversal by tachykinin neuropeptides
-
4. Yankner, B. A. et al. 1990. Neurotrophic and neurotoxic effects of amyloid β-protein: reversal by tachykinin neuropeptides. Science 250: 279-282.
-
(1990)
Science
, vol.250
, pp. 279-282
-
-
Yankner, B.A.1
-
5
-
-
0021173996
-
Development of a water-maze procedure for studying spatial learning in the rat
-
5. Morris, R. 1984. Development of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11: 47-60.
-
(1984)
J. Neurosci. Methods
, vol.11
, pp. 47-60
-
-
Morris, R.1
-
6
-
-
0019256571
-
Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia
-
6. Davies, P. et al. 1980. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288: 279-280.
-
(1980)
Nature
, vol.288
, pp. 279-280
-
-
Davies, P.1
-
7
-
-
0020316563
-
Cortical substance p-like immunoreactivity in cases of Alzheimer's disease and senile dementia of Alzheimer type
-
7. Crystal, H.A. and P. Davies. 1982. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of Alzheimer type. J. Neurochem. 38: 1781-1784.
-
(1982)
J. Neurochem.
, vol.38
, pp. 1781-1784
-
-
Crystal, H.A.1
Davies, P.2
-
8
-
-
0001141008
-
Alterations in neuropeptide Y in neurological disorders
-
Y. V. Mutt, Ed.. Raven Press. New York
-
8. Martin, J. B. et al. 1989. Alterations in neuropeptide Y in neurological disorders. In Neuropeptide. Y. V. Mutt, Ed.: 313-320. Raven Press. New York.
-
(1989)
Neuropeptide
, pp. 313-320
-
-
Martin, J.B.1
-
9
-
-
0032563342
-
Cholinergic lesions of the rat brain by ibotenic acid and 192IgG-saporin: Effects on somatostatin, substance P and neuropeptide Y levels in the cerebral cortex and the hippocampus
-
9. Nag, S. & F. Tang. 1998. Cholinergic lesions of the rat brain by ibotenic acid and 192IgG-saporin: effects on somatostatin, substance P and neuropeptide Y levels in the cerebral cortex and the hippocampus. Neurosci. Lett. 252: 83-86.
-
(1998)
Neurosci. Lett.
, vol.252
, pp. 83-86
-
-
Nag, S.1
Tang, F.2
|